QXO Swings to Q2 Loss, Revenue Rises-September 2024-www.financetom.com

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

QXO Swings to Q2 Loss, Revenue Rises

Aug 14, 2024 6:28 AM

09:03 AM EDT, 08/14/2024 (MT Newswires) -- QXO (QXO) reported a Q2 loss of $9.93 per diluted share, swinging from earnings of $0.52 a year earlier.

Revenue for the quarter ended June 30 was $14.54 million, up from $13.26 million.

Capital IQ estimates were not available.

QXO shares were 1.2% higher in premarket trading.

Price: 11.08, Change: +0.13, Percent Change: +1.19

Previous page： US considering revoking authorizations for Samsung, Hynix, TSMC in China - sources Next page： Google agrees $36 million fine for anti-competitive deals with Australia telcos

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

US considering revoking authorizations for Samsung, Hynix, TSMC in China - sources

Jun 20, 2025

* White House views plan as a contingency if trade truce fails * Move would make it harder for foreign chipmakers to operate in China * Move would be a gift to domestic Chinese competitors (Changes sourcing, adds comments on motive, chances throughout) By Karen Freifeld and Alexandra Alper June 20 (Reuters) - The Department of Commerce is considering revoking...

Google agrees $36 million fine for anti-competitive deals with Australia telcos

Aug 17, 2025

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...

Muscle-preserving drugs could generate over $30 billion in sales by 2035, TD Cowen says

Jun 20, 2025

By Bhanvi Satija June 20 (Reuters) - Treatments designed to help patients preserve muscle while losing weight with popular obesity drugs by Eli Lilly ( LLY ) and Novo Nordisk could generate more than $30 billion in sales by 2035, analysts at TD Cowen said on Friday. About a dozen companies are racing to develop such therapies, most of which...

BRIEF-Spectral IP Now Estimates IPO Price Between $4.00 And $5.00 Per Share

Jun 20, 2025

June 21 (Reuters) - Spectral IP Inc: * SPECTRAL IP INC - IPO PRICE NOW ESTIMATED BETWEEN $4.00 AND $5.00 PER SHARE - SEC FILING Source text: Further company coverage: ...